conclusion:
  outcome: 6 months of progression-free survival
  explanation: The patient's age, stage III colon adenocarcinoma, moderately differentiated differentiation histology, metastasis, and presence of carcinomatosis are factors that influence the progression-free survival. Comparing this case to the provided examples, the patient's condition is most similar to Example 3, but with a moderately differentiated tumor instead of a poorly differentiated one. This difference may result in a slightly better prognosis. However, the patient's older age may negatively impact the effectiveness of the treatment. Considering these factors, the expected progression-free survival under an optimal standard of care treatment plan is estimated to be around 6 months.